V-Bio Ventures is a Belgian venture capital firm investing in early-stage life-science companies. Willem Broekaer and Christina Takke co-founded the firm in 2015 to invest in startups throughout Europe. It focuses on companies that are active in the bio-pharmaceutical, diagnostic, and agriculture sectors. It collaborates closely with VIB (Vlaams Instituut voor Biotechnologie), a Belgium-based life sciences institute. Its portfolio companies include Confo Therapeutics, Augustine Therapeutics, Camel-IDS, OCTIMET Oncology, and Aphea.Bio.
Syndesi Therapeutics is a company developing molecules for the treatment of cognitive disorders of various neurological conditions.